Streetbeat News

Price Targets

NVDA

TD Cowen analyst Matthew Ramsay maintains an Outperform rating on NVIDIA (NASDAQ:NVDA) and raises the price target from $900 to $1100, indicating a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 3:41 pm

ASAN

Keybanc analyst Jason Ader downgraded Asana (NYSE:ASAN) from Sector Weight to Underweight and set a new price target of $14.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 3:39 pm

CLMT

Goldman Sachs analyst Neil Mehta maintains a Buy rating on Calumet Specialty Products (NASDAQ:CLMT) but lowers the price target from $19 to $17.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 3:38 pm

MU

TD Cowen analyst Krish Sankar maintains an Outperform rating on Micron Technology (NASDAQ:MU) and raises the price target from $120 to $150.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 3:37 pm

TSHA

Canaccord Genuity analyst Whitney Ijem has reiterated a Buy rating on Taysha Gene Therapies (NASDAQ:TSHA) and maintained a $7 price target.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 3:37 pm

SRAD

Canaccord Genuity analyst Michael Graham has reiterated a Buy rating on Sportradar Group (SRAD) and maintained a $16 price target.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 3:36 pm

BNTX

Canaccord Genuity analyst Bill Maughan reiterated a Buy rating on BioNTech (NASDAQ:BNTX) and maintained a $171 price target.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 3:33 pm

ALIT

Canaccord Genuity analyst Joseph Vafi maintains a Buy rating on Alight (NYSE:ALIT) and raises the price target from $12 to $13.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 3:32 pm

OABI

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on OmniAb (NASDAQ:OABI) and maintained an $11 price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 3:30 pm